Publication:
Clinical Profile and Outcome of COVID-19 Among Immunocompromised Children

Simple item page
dc.contributor.authorRao, Sunil Kumar
dc.contributor.authorKumar, Ashutosh
dc.contributor.authorPrasad, Rajniti
dc.contributor.authorGupta, Vineeta
dc.contributor.authorMishra, Om Prakash
dc.date.accessioned2025-01-30T06:00:33Z
dc.date.available2025-01-30T06:00:33Z
dc.date.issued2021
dc.description.abstractThis retrospective study describes the clinical profile, risk of infection and outcome of coronavirus disease-19 in immunocompromised children. It was found that children on immunosuppressant medication has 2.89 times increased risk of infection (P=0.01). Disease manifestation was asymptomatic (P=0.01) or mild with predominant gastrointestinal symptoms (P=0.02) without alteration in immunosuppressive treatment regime. � 2021, Indian Academy of Pediatrics.
dc.identifier.doihttps://doi.org/10.1007/s13312-021-2267-6
dc.identifier.issn196061
dc.identifier.urihttps://dl.bhu.ac.in/ir/handle/123456789/24866
dc.publisherSpringer
dc.subjectChildren
dc.subjectCOVID-19
dc.subjectImmunocompromised
dc.subjectOutcome
dc.titleClinical Profile and Outcome of COVID-19 Among Immunocompromised Children
dc.typeLetter
dspace.entity.typePublication
journal.titleIndian Pediatrics
journalvolume.identifier.volume58

Files

Collections

2021